Doctors & patients are saying about 'A-Fib.com'...

"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP.

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD Johns Hopkins,
Baltimore, MD

Doctors & patients are saying about 'Beat Your A-Fib'...

"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient,
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA

2026 AF Symposium: GLP-1 Improved Post Ablation A-Fib

Published July 14, 2026

7-14-26 10pm corrected missing link. | In my last 2026 AF Symposium report, I share with you one of the most impressive research findings of my reports. Potentially a new effective antiarrhythmic drug—and a new antiarrhythmic medication that works!

At this year’s AF Symposium, Dr. Gianluca Iacobellis (University of Miami, FL) gave a presentation entitled “The Role of GLP-1 RA on AF and AF Ablation Outcomes.”

GLP-1s (brand names Ozempic, Wegovy, Mounjaro, Victoza, and Zepbound) are primarily approved for type 2 diabetes management, but are also approved for chronic weight management.

Dr. Iacobellis presents findings from The Liraglutide Effects in Atrial Fibrillation (LEAF) Study. Researchers were looking to improve outcomes for persistent A-Fib patients undergoing catheter ablation. The objective was to test adjunctive therapy for three months pre-ablation with GLP-1 Liraglutide along with Risk Factor Modification for weight loss (typically includes changing lifestyle habits like diet and exercise, improving sleep and stress, and managing underlying conditions with medical support).

One goal was reduction in recurrent A-Fib at one-year. …>Continue reading for the remarkable findings. Go to me full report…>